Abiopharma

News list

Rosenblum Mark J 🟢 acquired 9.7K shares of Decoy Therapeutics Inc. (DCOY) Transaction Date: Aug 31, 2026 | Filing ID: 000003

Full text

News bot Sept. 2, 2026, 9:48 p.m.
🔍 Rosenblum Mark J (Executive)

Company: Decoy Therapeutics Inc. (DCOY)

Report Date: 2026-08-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 9,682
Detailed Transactions and Holdings:
- Acquired 9,682 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: false | shares_owned_after: 11,363.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan. 25 percent of the restricted stock vested immediately, and the remainder will vest in approximately equal monthly increments over the next 36 months.
- F2: Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026.